BioSpace News Archive

Conavi Medical is pleased to announce the first clinical use of the NovasightHybrid System, which enables simultaneous imaging of coronary arteries with both intravascular ultrasound and Optical Coherence Tomography.

Newark, NJ, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced the activation of a second clinical trial site for the phase I study of CPI-613 in combination with bendamustine in patients with relapsed or refractory T-Cell Lymphoma at the Abramson Cancer Center of the University of Pennsylvania. The primary objective of this study will be to determine the Maximum Tolerated Dose (MTD) of CPI-61

List identifies top U.S. cities with heightened vector pest pressure this summer

Technavio has announced their latest pipeline analysis report on the drug pipeline for hyperuricemia.

Zelluna Immunotherapy, the biotechnology company specializing in T-cell receptor (TCR) immunotherapies targeting a broad range of solid cancers with a high unmet medical need, today announces the appointment of Dr. Namir Hassan as chief scientific officer (CSO).

American Shared Hospital Services announced that proton therapy treatments have now resumed, following water damage to its proton therapy system at Orlando Health – UF Health Cancer Center that occurred on July 28, 2018.

Medical consumers now able to control their own health information with the benefit of IBM LinuxONE performance

Biopharmaceutical Veteran Appointed as Director of Clinical and Regulatory Affairs

Strategic guidance, strength of the new platform and integration are cited as keys to Agfa HealthCare’s success in driving desired outcomes for customers

Chicopee Gardens for Nursing and Rehabilitation is pleased to announce that Thomas Rackliffe, NHA has joined their ranks as their new Administrator.